Genius Group Limited

New York, New York--(Newsfile Corp. - July 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"), of the important August 28, 2026 lead plaintiff deadline. SO WHAT: If you purchased or sold Genius securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com - 2026-07-18 22:14:00

A 36.5% distribution yield paid in weekly slices pulls income investors toward the REX AI Equity Premium Income ETF (NASDAQ:AIPI).

247wallst.com - 2026-07-18 09:32:30

NEW YORK, July 17, 2026 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"), of the important August 28, 2026 lead plaintiff deadline. So What: If you purchased or sold Genius securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

prnewswire.com - 2026-07-17 22:40:00

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the “Class Period”), of the important August 28, 2026 lead plaintiff deadline.

globenewswire.com - 2026-07-17 19:54:00

New York, New York--(Newsfile Corp. - July 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"), of the important August 28, 2026 lead plaintiff deadline. SO WHAT: If you purchased or sold Genius securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com - 2026-07-16 21:34:00

NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Genius Group Limited (NYSE: GNS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Genius securities between April 12, 2022 and May 30, 2025, both dates inclusive (the “Class Period”).

globenewswire.com - 2026-07-15 12:00:00

Company sets July 31, 2026 as Record Date and issues qualifying details for second round of Share Loyalty Bonus Program. SINGAPORE, July 15, 2026 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) ("Genius Group", "GNS" or the "Company"), a leading AI-powered education group, today announced that all eligible shareholders for the first round of its Share Loyalty Bonus Program have been contacted to submit their payment instructions for payment processing, and that the record date for the second round of its Share Loyalty Bonus Program for the shareholders who choose to participate has been set for July 31, 2026, with the bonus set at $0.10 per share.

globenewswire.com - 2026-07-15 08:00:00

LOS ANGELES, July 15, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Genius Group Limited ("Genius" or "the Company") (NYSE American: GNS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of GNS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

prnewswire.com - 2026-07-15 05:01:00

NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed on behalf of investors in Genius securities, alleging violations of the federal securities laws by Citadel Securities LLC (“Citadel”) and Virtu Americas LLC (“Virtu” and, together with Citadel, the “Defendants”).    Such investors are advised to contact Danielle Peyton at  [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

globenewswire.com - 2026-07-14 17:34:00

NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the “Class Period”), of the important August 28, 2026 lead plaintiff deadline.

globenewswire.com - 2026-07-14 16:28:00

Genus PLC (LSE:GNS) said full-year profit is set to beat market expectations after stronger second-half trading and cash proceeds from its Chinese porcine joint venture strengthened the animal genetics group's balance sheet. Adjusted profit before tax for the year ended 30 June is expected to be approximately £98 million, ahead of the company-compiled consensus range of £94.3 million to £96.9 million.

proactiveinvestors.co.uk - 2026-07-14 06:06:51

New York, New York--(Newsfile Corp. - July 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"), of the important August 28, 2026 lead plaintiff deadline. SO WHAT: If you purchased or sold Genius securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com - 2026-07-13 20:25:00

GNS Investors Have Opportunity to Lead Genius Group Limited Securities Fraud Lawsuit with the Schall Law Firm PR Newswire

gurufocus.com - 2026-07-13 04:00:00

LOS ANGELES, July 13, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Genius Group Limited ("Genius" or "the Company") (NYSE American: GNS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 28, 2026.

prnewswire.com - 2026-07-13 03:45:00

New York, New York--(Newsfile Corp. - July 12, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"), of the important August 28, 2026 lead plaintiff deadline. SO WHAT: If you purchased or sold Genius securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com - 2026-07-12 20:20:00

NEW YORK, July 12, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Genius Group Limited (NYSE: GNS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Genius securities between April 12, 2022 and May 30, 2025, both dates inclusive (the “Class Period”).

globenewswire.com - 2026-07-12 12:00:00

NEW YORK, July 12, 2026 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"), of the important August 28, 2026 lead plaintiff deadline. So What: If you purchased or sold Genius securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

prnewswire.com - 2026-07-12 08:22:00

NEW YORK, July 11, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the “Class Period”), of the important August 28, 2026 lead plaintiff deadline.

globenewswire.com - 2026-07-11 20:54:00

New York, New York--(Newsfile Corp. - July 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"), of the important August 28, 2026 lead plaintiff deadline. SO WHAT: If you purchased or sold Genius securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com - 2026-07-11 20:15:00

New York, New York--(Newsfile Corp. - July 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"), of the important August 28, 2026 lead plaintiff deadline. SO WHAT: If you purchased or sold Genius securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com - 2026-07-10 20:10:00

LOS ANGELES, July 10, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Genius Group Limited (“Genius” or “the Company”) (NYSE American: GNS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 12, 2022 and May 30, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before August 28, 2026.

globenewswire.com - 2026-07-10 09:44:00

New York, New York--(Newsfile Corp. - July 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"), of the important August 28, 2026 lead plaintiff deadline. SO WHAT: If you purchased or sold Genius securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com - 2026-07-09 20:05:00

NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period").

globenewswire.com - 2026-07-08 23:21:02

NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 28, 2026.

globenewswire.com - 2026-07-08 23:21:00

NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz and Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Genius Group Limited (NYSE: GNS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Genius securities between April 12, 2022 and May 30, 2025, both dates inclusive (the "Class Period").

globenewswire.com - 2026-07-08 12:00:00

NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Genius Group Limited (NYSE: GNS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Genius securities between April 12, 2022 and May 30, 2025, both dates inclusive (the “Class Period”).

globenewswire.com - 2026-07-08 12:00:00

NEW YORK, July 7, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"). A class action lawsuit has already been filed.

prnewswire.com - 2026-07-07 19:04:00

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed on behalf of investors in Genius securities, alleging violations of the federal securities laws by Citadel Securities LLC (“Citadel”) and Virtu Americas LLC (“Virtu” and, together with Citadel, the “Defendants”).    Such investors are advised to contact Danielle Peyton at  [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

globenewswire.com - 2026-07-07 17:32:00

LOS ANGELES, July 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Genius Group Limited (“Genius” or “the Company”) (NYSE American: GNS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 12, 2022 and May 30, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before August 28, 2026.

globenewswire.com - 2026-07-07 11:14:00

LOS ANGELES, July 7, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Genius Group Limited ("Genius" or "the Company") (NYSE American: GNS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 28, 2026.

prnewswire.com - 2026-07-07 04:00:00

New York, New York--(Newsfile Corp. - July 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"). A class action lawsuit has already been filed.

newsfilecorp.com - 2026-07-06 22:23:00

New York, New York--(Newsfile Corp. - July 6, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Genius Group Limited (NYSE American: GNS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Genius securities between April 12, 2022 and May 30, 2025, both dates inclusive (the "Class Period").

newsfilecorp.com - 2026-07-06 12:00:00

NEW YORK, July 05, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period").

globenewswire.com - 2026-07-05 17:38:00

NEW YORK, July 05, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 28, 2026.

globenewswire.com - 2026-07-05 17:38:00

New York, New York--(Newsfile Corp. - July 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"). A class action lawsuit has already been filed.

newsfilecorp.com - 2026-07-05 14:23:00

Nationally Recognized Firm Urges Genius Investors to Explore Class Action Representation NEW YORK, July 5, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Genius Group Limited (NYSE: GNS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Genius securities between April 12, 2022 and May 30, 2025, both dates inclusive (the "Class Period").

prnewswire.com - 2026-07-05 12:00:00

New York, New York--(Newsfile Corp. - July 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"). A class action lawsuit has already been filed.

newsfilecorp.com - 2026-07-04 14:00:00

LOS ANGELES--(BUSINESS WIRE)---- $GNS--GNS Investors Have Opportunity to Lead Genius Group Limited Securities Fraud Lawsuit with the Schall Law Firm.

businesswire.com - 2026-07-03 15:56:00

New York, New York--(Newsfile Corp. - July 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"). A class action lawsuit has already been filed.

newsfilecorp.com - 2026-07-03 14:37:00

NEW YORK, July 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 28, 2026.

globenewswire.com - 2026-07-02 18:36:00

New York, New York--(Newsfile Corp. - July 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"). A class action lawsuit has already been filed.

newsfilecorp.com - 2026-07-02 14:32:00

New York, New York--(Newsfile Corp. - July 2, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nationally recognized investor-rights law

feeds.newsfilecorp.com - 2026-07-02 12:00:00

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Genius Group Limited (NYSE: GNS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Genius securities between April 12, 2022 and May 30, 2025, both dates inclusive (the “Class Period”).

globenewswire.com - 2026-07-01 16:53:00

NEW YORK, July 1, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"). A class action lawsuit has already been filed.

prnewswire.com - 2026-07-01 13:53:00

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025.For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.The Allegations: Rosen Law Firm is Investigating the Allegations that Citadel Securities LLC and Virtu Americas LLC Misled Investors Regarding its Manipulat.

businesswire.com - 2026-07-01 12:08:00

SINGAPORE, July 01, 2026 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) ("Genius Group", "GNS" or the "Company"), a leading AI-powered education group, today reported unaudited financial results of its operations for the second quarter ended June 30, 2026. The Company reported second quarter operational revenue of $3.2 million, a 112% increase from $1.5 million in Q2 2025.

globenewswire.com - 2026-07-01 08:00:00

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed on behalf of investors in Genius securities, alleging violations of the federal securities laws by Citadel Securities LLC (“Citadel”) and Virtu Americas LLC (“Virtu” and, together with Citadel, the “Defendants”).    Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

globenewswire.com - 2026-06-30 16:55:00

SINGAPORE, June 30, 2026 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) ("Genius Group", "GNS" or the "Company"), a leading AI-powered education group, has been notified that a class action lawsuit has been filed by its investors against Citadel Securities LLC and Virtu Americas LLC in the United States District Court Southern District of Florida. The complaint (Case No 1:26-cv-24485-XXXX), filed on June 29, 2026, is a class action lawsuit with Aron Reynolds named as Lead Plaintiff, individually and on behalf of all others similarly situated, vs Citadel Securities LLC and Virtu Americas LLC.

globenewswire.com - 2026-06-30 08:00:00

John Jumper and Noam Shazeer, two of Google's top AI talents, left for new employers in June. Alphabet is still a strong business without them.

fool.com - 2026-06-26 14:26:00

Investigational drug GNS561 showed a favorable safety and tolerability profile in a Phase 1b study evaluating its potential in combination with a MEK inhibitor (MEKi) Study conducted in a heavily pretreated, high-unmet-need population of KRAS-mutated cholangiocarcinoma (CCA) patients who had progressed after one or two failed lines of prior standard-of-care therapy Phase 2 initiation on track for initiation in 2H26 Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), June 23, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced positive Phase 1b results for GNS561 in combination therapy in patients with heavily pretreated cholangiocarcinoma, demonstrating a favorable safety and tolerability profile and early signs of antitumor activity. Clinical trial context and objective CCA is a rare and aggressive bile duct cancer, often diagnosed at an advanced stage.

globenewswire.com - 2026-06-23 12:00:00